Skip to main content

Invacare Holdings Corp

IVCDelisted Feb 16, 2023
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0000742112

Invacare Holdings Corp was delisted on Feb 16, 2023; its insiders filed their last Form 4 on Oct 31, 2024; 66 institutions reported holding it in 13F filings for Q4 2022, worth $7.88M in total; no superinvestor held it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 8, 2026, 11:30 AM ET

Revenue flow, FY2022

Where the revenue went in FY2022, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Net loss for FY2022: $101.1M (13.6% of revenue).

Income statement

Each column is one fiscal year, newest first.

Income statement of Invacare Holdings Corp, annual
Line itemFY2022FY2021FY2020FY2019FY2018
Period endDec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Filing10-K10-K10-K10-K10-K
ReportedFeb 1, 2023Mar 9, 2022Feb 10, 2021Feb 10, 2020Feb 13, 2019
Revenue$741.7M$872.5M$850.7M$928.0M$972.3M
Cost of revenue$566.3M$633.4M$605.4M$665.9M$704.7M
Gross profit$175.4M$239.1M$245.3M$262.1M$267.7M
Research and development$3.49M$8.66M$12.3M$15.8M$17.4M
Selling, general and administrative$226.8M$232.2M$236.4M$260.1M$281.9M
Operating income-$80.5M-$24.2M$11.3M-$10.4M-$18.3M
Interest expense$28.5M$24.3M$28.5M$29.1M$28.3M
Income tax$3.07M$6.45M$3.84M$9.30M$9.82M
Net income-$101.1M-$45.6M-$28.3M-$53.3M-$43.9M
EPS, basic$-2.77$-1.31$-0.83$-1.59$-1.33
EPS, diluted$-2.77$-1.31$-0.83$-1.59$-1.33
Weighted shares, basic36.5M34.9M34.3M33.6M33.1M
Weighted shares, diluted36.6M35.3M34.4M33.6M33.5M
Margins and growth
Gross margin23.6%27.4%28.8%28.2%27.5%
Operating margin-10.8%-2.8%1.3%-1.1%-1.9%
Net margin-13.6%-5.2%-3.3%-5.7%-4.5%
Revenue growth, year over year−15.0%+2.6%−8.3%−4.6%+0.6%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Invacare Holdings Corp, annual
Line itemFY2022FY2021FY2020FY2019FY2018
Period endDec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Filing10-K10-K10-K10-K10-K
ReportedFeb 1, 2023Mar 9, 2022Feb 10, 2021Feb 10, 2020Feb 13, 2019
Cash and equivalents$58.8M$83.7M$105.3M$80.1M$116.9M
Accounts receivable$88.0M$117.1M$108.6M$116.7M$119.7M
Inventory$112.6M$144.3M$115.5M$120.5M$128.1M
Total current assets$299.3M$385.4M$374.5M$355.9M$397.4M
Property, plant and equipment$51.5M$60.9M$56.2M$46.6M$74.3M
Goodwill$326.3M$355.9M$402.5M$373.4M$381.3M
Intangible assets$21.7M$26.4M$27.8M$26.4M$26.5M
Total assets$771.0M$909.5M$946.0M$852.1M$885.9M
Accounts payable$104.6M$130.0M$85.4M$88.0M$92.5M
Short-term debt$154.0K$3.11M$5.61M$58.0K$2.11M
Total current liabilities$220.1M$247.3M$230.4M$218.7M$198.2M
Long-term debt$354.1M$305.0M$239.4M$219.5M$253.5M
Shareholders' equity$81.1M$218.5M$333.8M$308.5M$359.1M

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Invacare Holdings Corp, annual
Line itemFY2022FY2021FY2020FY2019FY2018
Period endDec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Filing10-K10-K10-K10-K10-K
ReportedFeb 1, 2023Mar 9, 2022Feb 10, 2021Feb 10, 2020Feb 13, 2019
Operating cash flow-$55.3M-$14.3M$21.9M$2.74M–
Capital expenditures$3.78M$17.7M$22.3M$10.9M$9.82M
Free cash flow-$59.0M-$32.0M-$387.0K-$8.13M–
Depreciation and amortization$15.5M$16.8M$14.3M$15.6M$15.6M
Stock-based compensation$2.08M$4.32M$8.64M$11.1M$5.28M
Dividends paid$0$0$414.0K$1.65M$1.63M
Share buybacks$151.0K$1.75M$1.71M$894.0K$2.43M
Investing cash flow-$4.32M-$17.8M-$9.55M-$11.6M-$6.36M
Financing cash flow$38.3M$12.9M$6.26M-$27.9M-$2.92M
Net change in cash-$25.0M-$21.6M$25.2M-$36.8M-$59.6M
Ratio
Stock-based compensation, % of revenue0.3%0.5%1.0%1.2%0.5%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Invacare Holdings Corp by cover date
Cover dateShares outstandingChange in a yearFiling
May 12, 202310.0M–SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.